Quantcast
Last updated on April 20, 2014 at 17:20 EDT

Latest Applied genetics Stories

2013-05-09 12:28:32

-- Groundbreaking low pricing made possible by cutting-edge Next Generation Sequencing technology that is dramatically driving down costs -- HOUSTON, May 9, 2013 /PRNewswire/ -- FamilyTreeDNA.com, the genetic genealogy arm of Gene By Gene, Ltd., has lowered the price of its mid-level maternal line mtDNA test to $49, effective immediately. The company announced it will offer its mtDNAPlus product at a two-third price reduction permanently, in just its latest step toward universal...

2013-05-08 08:31:50

-- Amendment Helps to Protect Victims, Enhance Public Safety -- CARLSBAD, N.M., May 8, 2013 /PRNewswire-USNewswire/ -- Jayann Sepich, mother of murder victim Katie Sepich, and founder of DNA Saves (www.DNASaves.org) expressed appreciation for Sen. Hatch's (Utah) proposal to require DNA samples from undocumented immigrants applying for a special residency status, and for his continued commitment to victim issues. "My daughter was murdered by someone in the United States illegally,"...

2013-05-06 23:25:03

The latest in non invasive testing, Natus is coming to New York. New York (PRWEB) May 06, 2013 Natus, a leader in paternity testing, has just announced that they will be providing new offices and non invasive testing solutions, to residents living in New York. The company, a leader in paternity testing in the US, already has 2500 offices located around the US, and will now provide women the opportunity to use their services, and the latest forms of non invasive testing options, in the New...

2013-04-25 20:27:17

The gene could also be involved in breast and ovarian cancer An international research consortium led by the Universitat Autònoma de Barcelona (UAB), the CIBERER and the University of Wurzburg (Germany) has discovered a gene that can cause three totally different diseases, depending on how it is altered. The researchers, using next-generation massive ultrasequencing techniques, have sequenced the over 20,000 genes of a Fanconi anemia patient's genome. By adopting this...

2013-04-24 15:36:37

An investigational treatment for an inherited form of Lou Gehrig´s disease has passed an early phase clinical trial for safety, researchers at Washington University School of Medicine in St. Louis and Massachusetts General Hospital report. The researchers have shown that the therapy produced no serious side effects in patients with the disease, also known as amyotrophic lateral sclerosis (ALS). The phase 1 trial´s results, available online in Lancet Neurology, also demonstrate...

2013-04-19 16:23:15

SAN DIEGO, April 19, 2013 /PRNewswire/ -- Ceregene, Inc. today announced the top-line data from its double-blind, randomized, controlled Phase 2b clinical study of CERE-120 (AAV-neurturin), a gene therapy product designed to deliver the neurotrophic factor neurturin, for Parkinson's disease. The trial did not demonstrate statistically significant efficacy on the primary endpoint (UPDRS-motor off). However, one of the "key secondary endpoints" (Diary-off score), as defined and...

2013-03-29 23:15:04

On Saturday, April 6 from 2 p.m. to 4 p.m., Fatherhood Matters Inc., a San Antonio, Texas based non-profit organization will host I.AM.A.FATHER, an event in partnership with Identigene, providing a limited number of free DNA paternity tests to San Antonio families. The event is being held at the Boys & Girls Club of San Antonio. Salt Lake City, UT (PRWEB) March 29, 2013 On Saturday, April 6 from 2 p.m. to 4 p.m., Fatherhood Matters Inc., a San Antonio, Texas based non-profit...

2013-03-29 12:21:19

WASHINGTON, March 29, 2013 /PRNewswire-USNewswire/ -- The injection of antisense molecules into the space around the spinal cord of people with ALS is safe according to research published today. The first-in-human trial of this new therapy was funded by The ALS Association. The study was published today in the scientific journal Lancet Neurology. ALS, also known as Lou Gehrig's Disease, is a progressive neurodegenerative disease that affects nerve cells in the brain and the spinal cord. The...

2013-03-26 12:29:32

-- By Offering Low Cost DNA Test, Family Tree DNA Aims to Expand Reach of DNA Testing to Encourage Further Exciting Discoveries About Human Origins -- HOUSTON, March 26, 2013 /PRNewswire/ -- Gene By Gene, Ltd., the Houston-based genomics and genetics testing company, announced that a unique DNA sample submitted via National Geographic's Genographic Project to its genetic genealogy subsidiary, Family Tree DNA, led to the discovery that the most recent common ancestor for the Y...

2013-03-11 23:01:16

Paternity lab centers' growth is due to an increase in the number of visitors to its website which has gone from an average of 1200 to 2400 a week. (PRWEB) March 11, 2013 There are some who would say that the economy is in a terrible state but you can´t tell that to Kip Charles, the owner of the Paternity Lab Center. His business according to his accounts has seen growth each and every month for the last three months and he doesn´t see any end to growth in sight as yet. “We...